Molecure S.A.

4 trials 3 recruiting Commercial sponsor

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

3 Recruiting

0 Completed trials

7 Countries active

1 Unique IMPs

N/A Results reported

Phase II

Phase I

Phase I (Other)

Phase II: 2 Phase I: 1 Phase I (Other): 1

Top indications

Colorectal cancer 2 Renal cell carcinoma 2 Pulmonary sarcoidosis 2 Ovarian cancer 2

Top IMPs

5-(4-((2S,5S)-5-(4-CHLOROBENZYL)-2-METHYLMORPHOLINO)PIPERIDIN-1-YL)-1H- 1,2,4-TRIAZOL-3-AMINE 2

All trials

4 total

A study to assess the efficacy and safety of OATD-01 for the treatment of active pulmonary sarcoidosis. Not authorised

2023-506642-23-00 Phase II 6 countries 5-(4-((2S,5S)-5-(4-CHLOROBENZYL)-2-METHYLMORPHOLINO)PIPERIDIN-1-YL)-1H- 1,2,4-TR…
A study to assess the efficacy and safety of OATD-01 for the treatment of active pulmonary sarcoidosis. Recruiting

2023-506642-23-01 Phase II 6 countries 5-(4-((2S,5S)-5-(4-CHLOROBENZYL)-2-METHYLMORPHOLINO)PIPERIDIN-1-YL)-1H- 1,2,4-TR…
An open-label, multicentre, rollover study to evaluate safety and antineoplastic activity of OATD-02 in patients with selected advances and/… Recruiting

2024-513006-61-00 Phase I (Other) 1 country
An open-label, multicentre, dose-escalation, first-in-human phase I study to evaluate safety, tolerability and antineoplastic activity of OA… Recruiting

2024-510836-31-00 Phase I 1 country

Showing 1–4 of 4 trials

← All sponsors A–Z